# EDGAR Filing Document

**Accession Number:** 0001157075
**File Stem:** 0001683168-25-007214
**Filing Date:** 2025-9
**Character Count:** 2729
**Document Hash:** 57e45f5d50919036ae7e942c0b0f1d23
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-007214.hdr.sgml**: 20260127

**ACCESSION NUMBER**: 0001683168-25-007214

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250924

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PharmaCyte Biotech, Inc.
- **CENTRAL INDEX KEY:** 0001157075
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 621772151
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 3960 HOWARD HUGHES PARKWAY
- **STREET 2:** SUITE 500
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89169
- **BUSINESS PHONE:** (917) 595.2850

**MAIL ADDRESS:**
- **STREET 1:** 3960 HOWARD HUGHES PARKWAY
- **STREET 2:** SUITE 500
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89169

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NUVILEX, INC.
- **DATE OF NAME CHANGE:** 20090324

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EFOODSAFETY COM INC
- **DATE OF NAME CHANGE:** 20010808

**PharmaCyte Biotech, Inc.**

**3960 Howard Hughes Parkway, Suite 500**

**Las Vegas, NV 89169**

September 24, 2025

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jimmy McNamara

---

| | |
|:---|:---|
| Re: | **PharmaCyte Biotech, Inc.** |
|  | **Registration Statement on Form S-3** |
|  | **Filed September 17, 2025** |
|  | **File No. 333-290311 (the "Registration Statement")** |
|  | **Acceleration Request** |

---

Ladies and Gentlemen:

In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, PharmaCyte Biotech, Inc. (the "Registrant") hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Friday, September 26, 2025, at 4:00 p.m., Eastern Time, or as soon as thereafter practicable.

The cooperation of the staff in meeting the timetable described above is very much appreciated.

Please contact Kenneth R. Koch of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6768 with any questions regarding this request.

---

| |
|:---|
| Very truly yours, |
| PHARMACYTE BIOTECH, INC. |
| /s/ Joshua N. Silverman |
| Joshua N. Silverman |
| Chief Executive Officer, President and Chairman of the Board |

---

---

| | |
|:---|:---|
| cc: | *<u>Mintz, Levin. Cohn. Ferris. Glovsky and Popeo. P.C</u>* |
|  | Kenneth R. Koch, Esq. |
|  | Daniel A. Bagliebter, Esq. |
|  | Jeffrey D. Cohan, Esq. |

---